These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 2297696)
1. Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism. Kaplan O; Navon G; Lyon RC; Faustino PJ; Straka EJ; Cohen JS Cancer Res; 1990 Feb; 50(3):544-51. PubMed ID: 2297696 [TBL] [Abstract][Full Text] [Related]
3. Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: 31P and 13C nuclear magnetic resonance studies. Vivi A; Tassini M; Ben-Horin H; Navon G; Kaplan O Breast Cancer Res Treat; 1997 Mar; 43(1):15-25. PubMed ID: 9065595 [TBL] [Abstract][Full Text] [Related]
4. Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. Lyon RC; Cohen JS; Faustino PJ; Megnin F; Myers CE Cancer Res; 1988 Feb; 48(4):870-7. PubMed ID: 3338082 [TBL] [Abstract][Full Text] [Related]
5. Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy. Cohen JS; Lyon RC; Chen C; Faustino PJ; Batist G; Shoemaker M; Rubalcaba E; Cowan KH Cancer Res; 1986 Aug; 46(8):4087-90. PubMed ID: 3731076 [TBL] [Abstract][Full Text] [Related]
6. Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies. Jaroszewski JW; Kaplan O; Cohen JS Cancer Res; 1990 Nov; 50(21):6936-43. PubMed ID: 2208159 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies. Ben-Horin H; Tassini M; Vivi A; Navon G; Kaplan O Cancer Res; 1995 Jul; 55(13):2814-21. PubMed ID: 7796408 [TBL] [Abstract][Full Text] [Related]
8. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance. Politi PM; Sinha BK Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628 [TBL] [Abstract][Full Text] [Related]
9. 31P and 13C NMR spectroscopic study of wild type and multidrug resistant Ehrlich ascites tumor cells. Rasmussen J; Hansen LL; Friche E; Jaroszewski JW Oncol Res; 1993; 5(3):119-26. PubMed ID: 8260748 [TBL] [Abstract][Full Text] [Related]
10. Energy metabolism of adriamycin-sensitive and -resistant Ehrlich ascites tumor cells. Miccadei S; Fanciulli M; Bruno T; Paggi MG; Floridi A Oncol Res; 1996; 8(1):27-35. PubMed ID: 8704284 [TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance. Ogretmen B; McCauley MD; Safa AR Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006 [TBL] [Abstract][Full Text] [Related]
12. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Crawford KW; Bowen WD Cancer Res; 2002 Jan; 62(1):313-22. PubMed ID: 11782394 [TBL] [Abstract][Full Text] [Related]
13. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure. Khaitan D; Chandna S; Dwarakanath SB J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S67-73. PubMed ID: 20009299 [TBL] [Abstract][Full Text] [Related]
14. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells. Mimnaugh EG; Dusre L; Atwell J; Myers CE Cancer Res; 1989 Jan; 49(1):8-15. PubMed ID: 2535695 [TBL] [Abstract][Full Text] [Related]
15. Response-specific adriamycin sensitivity markers provided by in vivo 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas. Evelhoch JL; Keller NA; Corbett TH Cancer Res; 1987 Jul; 47(13):3396-401. PubMed ID: 3581077 [TBL] [Abstract][Full Text] [Related]
16. Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer. Kaplan O; Kushnir T; Askenazy N; Knubovets T; Navon G Cancer Res; 1997 Apr; 57(8):1452-9. PubMed ID: 9108445 [TBL] [Abstract][Full Text] [Related]
17. Cross-resistance to camptothecin analogues in a mitoxantrone-resistant human breast carcinoma cell line is not due to DNA topoisomerase I alterations. Yang CJ; Horton JK; Cowan KH; Schneider E Cancer Res; 1995 Sep; 55(18):4004-9. PubMed ID: 7664272 [TBL] [Abstract][Full Text] [Related]
18. Two-deoxyglucose as an anti-metabolite in human carcinoma cell line RPMI-2650 and drug-resistant variants. Keenan J; Liang Y; Clynes M Anticancer Res; 2004; 24(2A):433-40. PubMed ID: 15152941 [TBL] [Abstract][Full Text] [Related]
19. Quantitative differential effects of rhodamine 123 on normal cells and human colon cancer cells by magnetic resonance spectroscopy. Singer S; Neuringer LJ; Thilly WG; Chen LB Cancer Res; 1993 Dec; 53(23):5808-14. PubMed ID: 8242640 [TBL] [Abstract][Full Text] [Related]
20. Relationships between cytosolic [ATP], [ATP]/[ADP] and ionic fluxes in the perfused rat heart: A 31P, 23Na and 87Rb NMR study. Stewart LC; Deslauriers R; Kupriyanov VV J Mol Cell Cardiol; 1994 Oct; 26(10):1377-92. PubMed ID: 7869398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]